BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 3004704)

  • 1. Mechanisms of growth inhibition by anti-transferrin receptor monoclonal antibodies.
    Taetle R; Castagnola J; Mendelsohn J
    Cancer Res; 1986 Apr; 46(4 Pt 1):1759-63. PubMed ID: 3004704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of monoclonal anti-transferrin receptor antibodies on in vitro growth of human solid tumor cells.
    Taetle R; Honeysett JM
    Cancer Res; 1987 Apr; 47(8):2040-4. PubMed ID: 3828993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combinations of anti-transferrin receptor monoclonal antibodies inhibit human tumor cell growth in vitro and in vivo: evidence for synergistic antiproliferative effects.
    White S; Taetle R; Seligman PA; Rutherford M; Trowbridge IS
    Cancer Res; 1990 Oct; 50(19):6295-301. PubMed ID: 2400993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of epidermal growth factor on transferrin receptor phosphorylation and surface expression in malignant epithelial cells.
    Castagnola J; MacLeod C; Sunada H; Mendelsohn J; Taetle R
    J Cell Physiol; 1987 Sep; 132(3):492-500. PubMed ID: 3498729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative studies of the binding and growth-supportive ability of mammalian transferrins in human cells.
    Penhallow RC; Brown-Mason A; Woodworth RC
    J Cell Physiol; 1986 Aug; 128(2):251-60. PubMed ID: 3015988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptor-mediated endocytosis of human transferrin and its cell surface receptor.
    Larrick JW; Enns C; Raubitschek A; Weintraub H
    J Cell Physiol; 1985 Aug; 124(2):283-7. PubMed ID: 2995416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of all-trans retinoic acid and antireceptor antibodies on growth and programmed cell death of human myeloma cells.
    Taetle R; Dos Santos B; Akamatsu K; Koishihara Y; Ohsugi Y
    Clin Cancer Res; 1996 Feb; 2(2):253-9. PubMed ID: 9816167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of the transferrin receptor in the production and NK-induced suppression of human antibody synthesis.
    Brieva JA; Stevens RH
    J Immunol; 1984 Sep; 133(3):1288-92. PubMed ID: 6205077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of human single-chain antibodies to the transferrin receptor that effectively antagonize the growth of leukemias and lymphomas.
    Crépin R; Goenaga AL; Jullienne B; Bougherara H; Legay C; Benihoud K; Marks JD; Poul MA
    Cancer Res; 2010 Jul; 70(13):5497-506. PubMed ID: 20530676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Murine cell surface transferrin receptor: studies with an anti-receptor monoclonal antibody.
    Trowbridge IS; Lesley J; Schulte R
    J Cell Physiol; 1982 Sep; 112(3):403-10. PubMed ID: 6290505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of human syncytiotrophoblast plasma membrane-soluble extracts on in vitro mitogen-induced lymphocyte proliferation. A possible inhibition mechanism involving the transferrin receptor.
    Khalfoun B; Degenne D; Crouzat-Reynes G; Bardos P
    J Immunol; 1986 Aug; 137(4):1187-93. PubMed ID: 3016089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of transferrin, Fe, and transferrin receptors in myeloid leukemia cell growth. Studies with an antitransferrin receptor monoclonal antibody.
    Taetle R; Rhyner K; Castagnola J; To D; Mendelsohn J
    J Clin Invest; 1985 Mar; 75(3):1061-7. PubMed ID: 2984253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of transferrin receptor-dependent GaC-Tf-FeN transport in human leukemic HL60 cells.
    Li YQ; Liu B; Zhao CG; Zhang W; Yang BS
    Clin Chim Acta; 2006 Apr; 366(1-2):225-32. PubMed ID: 16360136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disparity between expression of transferrin receptor ligand binding and non-ligand binding domains on human lymphocytes.
    Boldt DH; Phillips JL; Alcantara O
    J Cell Physiol; 1987 Aug; 132(2):331-6. PubMed ID: 3624319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase Ia trial of murine immunoglobulin A antitransferrin receptor antibody 42/6.
    Brooks D; Taylor C; Dos Santos B; Linden H; Houghton A; Hecht TT; Kornfeld S; Taetle R
    Clin Cancer Res; 1995 Nov; 1(11):1259-65. PubMed ID: 9815920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of tumor cell growth by aggregation of a tumor-associated glycolipid antigen: a close functional association between gangliotriaosylceramide and transferrin receptor in mouse lymphoma L-5178Y.
    Okada Y; Matsuura H; Hakomori S
    Cancer Res; 1985 Jun; 45(6):2793-801. PubMed ID: 2985252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cloning, characterization, and modeling of a monoclonal anti-human transferrin antibody that competes with the transferrin receptor.
    Orlandini M; Santucci A; Tramontano A; Neri P; Oliviero S
    Protein Sci; 1994 Sep; 3(9):1476-84. PubMed ID: 7530542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of monoclonal antibodies that block transferrin receptor function on the in vivo growth of a syngeneic murine leukemia.
    Sauvage CA; Mendelsohn JC; Lesley JF; Trowbridge IS
    Cancer Res; 1987 Feb; 47(3):747-53. PubMed ID: 3802079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transferrin receptor-mediated suppression of in vitro hematopoiesis by transferrin-gallium.
    Chitambar CR; Craig A; Ash RC
    Exp Hematol; 1989 Jun; 17(5):418-22. PubMed ID: 2714421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the acidic receptosome in the uptake and retention of 67Ga by human leukemic HL60 cells.
    Chitambar CR; Zivkovic-Gilgenbach Z
    Cancer Res; 1990 Mar; 50(5):1484-7. PubMed ID: 2302713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.